We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.39B
1-Year Est. Return 1.06%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
-1.06%
3 Year Est. Return
+72.63%
5 Year Est. Return
+112.03%
10 Year Est. Return
+415.67%
AUM
$4.37B
AUM Growth
+$566M
Cap. Flow
+$197M
Cap. Flow %
4.52%
Top 10 Hldgs %
75.62%
Holding
311
New
26
Increased
196
Reduced
22
Closed
17

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$25.9M
2
MSGS icon
Madison Square Garden
MSGS
+$23.3M
3
MSFT icon
Microsoft
MSFT
+$14.8M
4
AMZN icon
Amazon
AMZN
+$12.7M
5
NVDA icon
NVIDIA
NVDA
+$12.5M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$41.6M
2
DINO icon
HF Sinclair
DINO
+$6.4M
3
UNH icon
UnitedHealth
UNH
+$3.72M
4
TPYP icon
Tortoise North American Pipeline ETF
TPYP
+$2.48M
5
FANG icon
Diamondback Energy
FANG
+$2.11M

Sector Composition

Rank Sector Weight
1 Healthcare 56.07%
2 Technology 8.45%
3 Energy 6.73%
4 Consumer Discretionary 4.64%
5 Utilities 4.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVS icon
101
CVS Health
CVS
$137B
$1.53M 0.04%
22,191
+457
+2% +$30K
BKH icon
102
Black Hills Corp
BKH
$5.73B
$1.51M 0.03%
26,947
+1,508
+6% +$88.3K
VERA icon
103
Vera Therapeutics
VERA
$2.54B
$1.51M 0.03%
+64,042
New +$1.44M
CARR icon
104
Carrier Global
CARR
$57.2B
$1.46M 0.03%
19,987
+530
+3% +$36K
PD icon
105
PagerDuty
PD
$700M
$1.45M 0.03%
+94,658
New +$1.47M
ESTC icon
106
Elastic
ESTC
$6.1B
$1.43M 0.03%
+16,924
New +$1.43M
NRIX icon
107
Nurix Therapeutics
NRIX
$2.43B
$1.4M 0.03%
+122,782
New +$1.33M
EOG icon
108
EOG Resources
EOG
$78B
$1.39M 0.03%
11,654
+346
+3% +$39.5K
CMCSA icon
109
Comcast
CMCSA
$79.1B
$1.38M 0.03%
38,776
+617
+2% +$21.3K
ES icon
110
Eversource Energy
ES
$28.2B
$1.37M 0.03%
21,476
+1,187
+6% +$73.2K
CNTA
111
DELISTED
Centessa Pharmaceuticals
CNTA
$1.32M 0.03%
+100,362
New +$1.27M
HELP
112
Cybin Inc
HELP
$472M
$1.32M 0.03%
+156,954
New +$1.14M
RIO icon
113
Rio Tinto
RIO
$148B
$1.3M 0.03%
22,282
+2,121
+11% +$125K
MMM icon
114
3M
MMM
$89B
$1.25M 0.03%
8,195
+256
+3% +$36.6K
TENB icon
115
Tenable Holdings
TENB
$3.56B
$1.16M 0.03%
+34,277
New +$1.11M
OTIS icon
116
Otis Worldwide
OTIS
$27.4B
$1.15M 0.03%
11,643
+356
+3% +$34.4K
IWB icon
117
iShares Russell 1000 ETF
IWB
$47.7B
$1.13M 0.03%
3,318
+9
+0.3% +$2.83K
UL icon
118
Unilever
UL
$131B
$1.09M 0.02%
15,854
-452
-3% -$31.7K
AMGN icon
119
Amgen
AMGN
$203B
$1.09M 0.02%
3,898
+215
+6% +$60.9K
MAR icon
120
Marriott International
MAR
$98.7B
$1.04M 0.02%
3,795
+191
+5% +$47.9K
VTI icon
121
Vanguard Total Stock Market ETF
VTI
$654B
$1.01M 0.02%
3,334
-296
-8% -$83.3K
NSC icon
122
Norfolk Southern
NSC
$78.8B
$937K 0.02%
3,661
+200
+6% +$47.2K
DT icon
123
Dynatrace
DT
$12.1B
$915K 0.02%
+16,566
New +$830K
PRME icon
124
Prime Medicine
PRME
$533M
$892K 0.02%
361,136
– –
TYL icon
125
Tyler Technologies
TYL
$12.2B
$867K 0.02%
+1,462
New +$828K
3 4
5
6 7

Similar funds

BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return

Bollard Group's Q2 2025 Portfolio in Review

As of Q2 2025, Bollard Group held 311 positions worth $4.37B, up 15% from $3.81B the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Bollard Group deployed $197M of net new capital in Q2 2025, opening 26 new positions and adding to 196 existing holdings. Its largest new stake was Madison Square Garden: 121,000 shares worth $25.3M.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, down from 61% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Boston Scientific, an estimated $41.6M trimmed.

  • Bollard Group's largest Q2 2025 buy was Madison Square Garden: 121,000 shares worth $25.3M.
  • Bollard Group added most to Thermo Fisher Scientific in Q2 2025, an estimated $25.9M increase.
  • Bollard Group's biggest Q2 2025 reduction was Boston Scientific, cutting an estimated $41.6M.
  • Bollard Group fully exited HF Sinclair in Q2 2025, selling an estimated $6.4M.
  • Bollard Group's ten largest holdings make up 76% of its $4.37B portfolio in Q2 2025.
  • Bollard Group opened 26 new positions and closed 17 in Q2 2025.
  • Bollard Group's portfolio value rose 15% quarter-over-quarter to $4.37B.

Based on Bollard Group's 13F filing for Q2 2025, filed 13 Aug 2025.